DEUTSCHE BANK AG\ - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 53 filers reported holding OMEGA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,307
-61.6%
1,5380.0%0.00%
Q2 2023$8,613
-88.8%
1,538
-87.5%
0.00%
Q1 2022$77,000
+51.0%
12,337
+174.4%
0.00%
Q4 2021$51,000
-36.2%
4,496
+5.6%
0.00%
Q3 2021$80,0004,2560.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$6,653,0008.31%
CHI Advisors LLC 1,055,882$19,904,0005.81%
Flagship Pioneering Inc. 25,902,269$488,258,0005.11%
HARBOURVEST PARTNERS LLC 2,647,059$49,897,0004.69%
Octagon Capital Advisors LP 370,279$6,980,0001.72%
Monashee Investment Management LLC 441,176$8,316,0001.54%
Artal Group S.A. 2,273,530$42,856,0000.96%
SPHERA FUNDS MANAGEMENT LTD. 527,948$9,952,0000.84%
PLATINUM INVESTMENT MANAGEMENT LTD 500,000$9,425,0000.26%
Logos Global Management LP 88,235$1,663,0000.12%
View complete list of OMEGA THERAPEUTICS INC shareholders